The safety of combined administration of ultralow doses of antigens to endothelial NO synthase (impaza) and nitrates for the treatment of erectile dysfunction in CHD patients was evaluated in an open non-comparative clinical trial. The efficiency and safety of impaza and the possibility of its administration to patients receiving nitrates were demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. B. Mazo, S. I. Gamidov, R. I. Ovchinnikov, and V. V. Iremashvili, Farmateka, No. 4-5, 40-45 (2005).
A. V. Martyushev-Poklad and O. I. Epshtein, Poliklinika No. 1, p. 8-9 (2003).
E. G. Mutalova, Sh. Z. Sattarov, A. E. Nigmatulina, and B. N. Golubkova, Lechashchii Vrach, No 7, 86-88 (2006).
H. Brunner, Cockcroft J.R., Deanfield J. et al. J. Hypertens., 23, No. 2, 233-246 (2005).
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H. Boger, Vasc. Med., 7, No. 3, 213-225 (2002).
R. A. Stein, Rev. Urol. Vol. 5. 21-27 (2003).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 74-75, August, 2009
Rights and permissions
About this article
Cite this article
Zhavbert, E.S., Kachanova, M.V., Tarasov, S.A. et al. Evaluation of the Efficiency and Safety of Combined Treatment with Impaza and Nitrates in CHD Patients with Erectile Dysfunction. Bull Exp Biol Med 148, 325 (2009). https://doi.org/10.1007/s10517-009-0688-7
Received:
Published:
DOI: https://doi.org/10.1007/s10517-009-0688-7